Literature DB >> 11199941

Treating neuroleptic malignant syndrome as catatonia.

M Fink.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11199941     DOI： 10.1097/00004714-200102000-00028

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  5 in total

Review 1.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

2.  A case of catatonia and neuroleptic malignant syndrome probably associated with antipsychotic in Korea.

Authors:  Ho-Dong Choi; Kyoung-Keun Kim; Bon-Hoon Koo
Journal:  Psychiatry Investig       Date:  2011-01-10       Impact factor: 2.505

Review 3.  Managing an effective treatment for neuroleptic malignant syndrome.

Authors:  Udo Reulbach; Carmen Dütsch; Teresa Biermann; Wolfgang Sperling; Norbert Thuerauf; Johannes Kornhuber; Stefan Bleich
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

4.  Catatonia versus neuroleptic malignant syndrome: the diagnostic dilemma and treatment.

Authors:  Manoj Kumar Sahoo; Sanjay Agarwal; Harshita Biswas
Journal:  Ind Psychiatry J       Date:  2014 Jul-Dec

5.  Diagnostic and Therapeutic Challenges of Catatonia in an Adolescent With High Functioning Autism Spectrum Disorder: A Case Report.

Authors:  Annalisa Traverso; Caterina Ancora; Silvia Zanato; Alessia Raffagnato; Michela Gatta
Journal:  Front Psychiatry       Date:  2021-06-02       Impact factor: 4.157
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.